Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2743-40-0

Post Buying Request

2743-40-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2743-40-0 Usage

Chemical Properties

Crystalline

Uses

L-Leucine ethyl ester hydrochloride is used as an organic chemical synthesis intermediate.

Check Digit Verification of cas no

The CAS Registry Mumber 2743-40-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,7,4 and 3 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 2743-40:
(6*2)+(5*7)+(4*4)+(3*3)+(2*4)+(1*0)=80
80 % 10 = 0
So 2743-40-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H17NO2/c1-4-11-8(10)7(9)5-6(2)3/h6-7H,4-5,9H2,1-3H3

2743-40-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (L0123)  L-Leucine Ethyl Ester Hydrochloride  >99.0%(T)

  • 2743-40-0

  • 25g

  • 690.00CNY

  • Detail
  • TCI America

  • (L0123)  L-Leucine Ethyl Ester Hydrochloride  >99.0%(T)

  • 2743-40-0

  • 250g

  • 2,890.00CNY

  • Detail
  • Alfa Aesar

  • (L13147)  L-Leucine ethyl ester hydrochloride, 97%   

  • 2743-40-0

  • 5g

  • 222.0CNY

  • Detail
  • Alfa Aesar

  • (L13147)  L-Leucine ethyl ester hydrochloride, 97%   

  • 2743-40-0

  • 25g

  • 879.0CNY

  • Detail
  • Aldrich

  • (61850)  L-Leucineethylesterhydrochloride  ≥99.0% (AT)

  • 2743-40-0

  • 61850-10G-F

  • 803.79CNY

  • Detail

2743-40-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl (2S)-2-amino-4-methylpentanoate,hydrochloride

1.2 Other means of identification

Product number -
Other names dl-leucine ethyl ester hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2743-40-0 SDS

2743-40-0Relevant articles and documents

Modulation of the binding affinity of naproxen to bovine serum albumin by conversion of the drug into amino acid ester salts

?wiatek, Ewelina,Guncheva, Maya,Janus, Ewa,Kardaleva, Proletina,Klebeko, Joanna,Krachmarova, Elena,Ossowicz, Paula,Rangelov, Miroslav,Taneva, Stefka,Todorova, Nadezhda

, (2020/10/18)

Naproxen (NAP) is one of the most widely prescribed non-steroidal anti-inflammatory drugs. Novel formulations of NAP aiming at better water-solubility, dosage, and the onset of action or new routes of application in order to minimize or prevent side effects of NAP are in the current interest of the pharmaceutical industry. Here, we report the synthesis, chemical, spectral and physicochemical characterization of a series of salts containing cations amino acid alkyl esters (AAE) and NAP anion, which potentially can be used as novel drug formulation. The [L-AAE][NAP] were obtained in three steps: preparation of the AAE hydrochlorides, neutralization of the hydrochlorides to the corresponding AAE, and formation of the target organic salts. All NAP derivatives, tested at a concentration as high as 100 μM, exhibited no toxicity against murine macrophage cell line (RAW 264.7). The binding parameters and stoichiometry of [AAE][NAP]s to bovine serum albumin (BSA) are in the range of that estimated for the parent NAP. Only L-valine isopropyl ester naproxenate characterizes with about one order of magnitude lower binding affinity for BSA, which suggests a faster diffusion rate in the circulatory system than the parent NAP and other derivatives, and therefore faster reach to the target system. Using molecular modeling seven binding pockets of BSA were probed for their suitability to binds the cation and the anion and results are discussed in correlation with the obtained thermodynamic parameters for the binding of NAP derivatives to BSA.

Synthesis, spectroscopic characterization, and in vitro antibacterial evaluation of novel functionalized sulfamidocarbonyloxyphosphonates

Bouzina, Abdeslem,Bechlem, Khaoula,Berredjem, Hajira,Belhani, Billel,Becheker, Imène,Lebreton, Jacques,Le Borgne, Marc,Bouaziz, Zouhair,Marminon, Christelle,Berredjem, Malika

, p. 1 - 14 (2018/07/31)

Several new sulfamidocarbonyloxyphosphonates were prepared in two steps, namely carbamoylation and sulfamoylation, by using chlorosulfonyl isocyanate (CSI), α-hydroxyphosphonates, and various amino derivatives and related (primary or secondary amines, β-amino esters, and oxazolidin-2-ones). All structures were confirmed by 1H, 13C, and 31P NMR spectroscopy, IR spectroscopy, and mass spectroscopy, as well as elemental analysis. Eight compounds were evaluated for their in vitro antibacterial activity against four reference bacteria including Gram-positive Staphylococcus aureus (ATCC 25923), and Gram-negative Escherichia coli (ATCC 25922), Klebsiella pneumonia (ATCC 700603), Pseudomonas aeruginosa (ATCC 27853), in addition to three clinical strains of each studied bacterial species. Compounds 1a–7a and 1b showed significant antibacterial activity compared to sulfamethoxazole/trimethoprim, the reference drug used in this study.

Enantioselective synthesis of α-secondary and α-tertiary piperazin-2- Ones and piperazines by catalytic asymmetric allylic alkylation

Korch, Katerina M.,Eidamshaus, Christian,Behenna, Douglas C.,Stoltz, Brian M.,Nam, Sangkil,Horne, David

supporting information, p. 179 - 183 (2015/02/05)

The asymmetric palladium-catalyzed decarboxylative allylic alkylation of differentially N-protected piperazin-2- ones allows the synthesis of a variety of highly enantioenriched tertiary piperazine-2-ones. Deprotection and reduction affords the corresponding tertiary piperazines, which can be employed for the synthesis of medicinally important analogues. The introduction of these chiral tertiary piperazines resulted in imatinib analogues which exhibited comparable antiproliferative activity to that of their corresponding imatinib counterparts.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2743-40-0